Tag: AI drug development

Alphabet-owned company to begin human trials for cancer drug developed using AI

Alphabet-owned company to begin human trials for cancer drug developed using AI

cpooldigitalLeave a Comment on Alphabet-owned company to begin human trials for cancer drug developed using AI

Pharmaceutical firm Isomorphic Labs is set to initiate human clinical trials for its oncology drugs created using AlphaFold 3, an AI tool developed by the company in collaboration with Google DeepMind.  Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently  preparing to dose the first patients with the AI-engineered […]

Continue Reading
Google DeepMind CEO predicts AGI in 5-10 years but says AI still lacks imagination

Google DeepMind CEO predicts AGI in 5-10 years but says AI still lacks imagination

cpooldigitalLeave a Comment on Google DeepMind CEO predicts AGI in 5-10 years but says AI still lacks imagination

Google DeepMind CEO Demis Hassabis has said that artificial general intelligence (AGI) or AI systems capable of human-level cognitive abilities could be five to ten years away. However, the Nobel Prize-winning AI researcher ruled out that today’s AI systems possess any form of consciousness. He also acknowledged that these AI tools are lacking in imagination. […]

Continue Reading